Molecular medicine in lung cancer

Precision medicine enabled histology agnostic development of immunotherapeutics

Synthetic lethality as a basis to select drug combinations

Genomic predictors of treatment response in prostate cancer

Redesigning clinical trials in the era of precision medicine

Novel models to personalise cancer therapeutics

Genomic analysis of childhood tumours; biological and therapeutic implications

Biomarker research in breast cancer

Big data, scientific wellness and transforming healthcare

Genomic-driven clinical studies in breast cancer

Current and future immune approaches in precision medicine

Bayesian adaptive trial designs for precision medicine

Proteogenomics in cancer research

Patient-specific peptide vaccines

DNA damage response inhibition

New biomarkers for response to immunotherapy

Incorporating liquid biopsies into clinical trials

Combining immune-based therapies with TKIs in melanomas